Showing results (41-50 of 179) with videos related to

Sort By:
Pageof 18
Expert Review of Gastroenterology & Hepatology|September 9, 2025
Non-invasive assessment of liver fibrosis in MASLD: the need of sex-adjusted scoresFabio Novielli, Carlo De Matteis, Antonio Moschetta, et al.
Cell Reports|March 25, 2014
Microbiota modification with probiotics induces hepatic bile acid synthesis via downregulation of the Fxr-Fgf15 axis in miceChiara Degirolamo, Stefania Rainaldi, Fabiola Bovenga, et al.
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|February 7, 2003
Pathobiology of cholesterol gallstone disease: from equilibrium ternary phase diagram to agents preventing cholesterol crystallization and stone formationPiero Portincasa, Antonio Moschetta, Giuseppe Calamita, et al.
World Journal of Gastroenterology|October 17, 2003
Pan-enteric dysmotility, impaired quality of life and alexithymia in a large group of patients meeting ROME II criteria for irritable bowel syndromePiero Portincasa, Antonio Moschetta, Giuseppe Baldassarre, et al.
Nutrients|September 7, 2019
Extra Virgin Olive Oil: Lesson from NutrigenomicsStefania De Santis, Marica Cariello, Elena Piccinin, et al.
Wiley Interdisciplinary Reviews. Systems Biology and Medicine|July 15, 2011
Lipid-sensing nuclear receptors in the pathophysiology and treatment of the metabolic syndromeMichele Vacca, Chiara Degirolamo, Renato Mariani-Costantini, et al.
The Journal of Nutritional Biochemistry|September 15, 2007
Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesisIgnazio Grattagliano, Vincenzo O Palmieri, Piero Portincasa, et al.
Current Pharmaceutical Design|July 14, 2007
Targeting the liver in the metabolic syndrome: evidence from animal modelsMichele Petruzzelli, Giuseppe Lo Sasso, Piero Portincasa, et al.
Cancer Research|December 3, 2008
Nuclear bile acid receptor FXR protects against intestinal tumorigenesisSalvatore Modica, Stefania Murzilli, Lorena Salvatore, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|October 3, 2017
Nuclear receptor FXR, bile acids and liver damage: Introducing the progressive familial intrahepatic cholestasis with FXR mutationsMarica Cariello, Elena Piccinin, Oihane Garcia-Irigoyen, et al.
Pageof 18